Tumorigenicity investigation of CNE2 cell line STGC3 expression induced by tet-on system in nude mice

Progress in Biochemistry and Biophysics

Volumn 34, Issue 4, 2007, Pages 359-365

  Qiu, Qing Chao ^a   Hu, Bo ^a   He, Xiu Sheng ^a   Luo, Qiao ^a   Long, Zhi Feng ^a   Tang, Guo Hua ^a   Liao, Yin Hua ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Nasopharyngeal carcinoma; Nude mice; STGC3 gene; Tet on regulating expression system

Indexed keywords

MUS MUSCULUS;

EID: 34547280971     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Zeng Z, Zhou Y, Zhang W, et al. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med, 2006, 8 (3): 156- 160
2. Yu M C, Yuan J M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol, 2002, 12 (6): 421-429
3. Loh K S, Goh B C, Lu J, et al. Familial nasopharyngeal carcinoma in a cohort of 200 patients. Arch Otolaryngol Head Neck Surg, 2006, 132(1): 82-85
4. Quo X C, Scott K, Liu Y, et al. Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility. Hum Genomics, 2006, 2 (6): 365-375
5. Lo K, Huang P W, Lee C K. Genetic changes in nasopharyngeal carcinoma. Chin Med J (Engl), 1997, 110 (7): 548-549
6. Yau W L, Lung H L, Zabarovsky E R, et al. Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma. Int J Cancer, 2006, 119 (12): 2821-2826
7. Xiong W, Zeng Z Y, Xia J H, et al. A susceptibility locus at chromosome 3p21 linked to family nasopharyngeal carcinoma. Cancer Res, 2004, 64 (6): 1972-1974
8. He X S, Chen Z C, Tian F, et al. Chin J Cancer, 2003, 22 (1): 1-5
9. He X S, Chen Z C, Zhu J H, et al. Chin J Cancer, 2004, 23 (10): 1110-1115
10. Deng M, He X S, Luo Q, et al. Prog Biochem Biophys, 2006, 33 (1): 39-44
11. Zeng J, Li Z B, Luo S Q, et al. Retrovirus-mediated tk gene therapy of implanted human breast cancer in nude mice under the regulation of Tet-On. Cancer Gene Therapy, 2006, 13 (3): 290-297
12. Maedal K, Hobbs R M, Merghoub T, et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature, 2005, 433 (20): 278-285
13. Xie X, Clausen O P, de Angelis P, et al. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer, 1999, 86 (6): 913-920
14. Roth J A, Nguyen D, Lawrence D D, et al. Retrovirus-mediated p53 gene transfer to tumors of patients with lung cancer. Nat Med, 1996, 2 (9): 985-991
15. Windle J J, Albert D M, O"Brien J M, et al. Retinoblastoma in transgenic mice. Nature, 1990, 343 (6259): 665-669
16. ElOjeimy S, McKillop J C, El-Zawahry A M, et al. Fast gene therapy: a new therapeutic modality for head and neck cancer. Cancer Gene Ther, 2006, 13 (8): 739-745
17. Das S, Somasundaram K. Therapeutic potential of an adenovirus expressing p73 beta, a p53 homologue, against human papilloma virus positive cervical cancer in vitro and in vivo. Cancer Biol Ther, 2006, 5 (2): 210-217
18. Krishna S M, James S, Kattoor 3, et al. Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin. Jpn J Clin Oncol, 2004, 34 (6): 307-311